Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Antacid monograph amendment

This article was originally published in The Tan Sheet

Executive Summary

Antacid monograph amendment: FDA deletes parts of the monograph's testing procedures, including the acid neutralizing capacity test, in a Feb. 8 Federal Register notice. The deleted sections are being replaced with reference to the U.S. Pharmacopeia National Formulary, which has been updated. The "test modification" section is being retained, the notice states, in case manufacturers need to petition for a proposed modification. This action finalizes a Sept. 23, 1993 proposed rule made in an effort to align the monograph with USP recommendations ("The Tan Sheet" Sept. 27, 1993)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084758

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel